Northern Trust’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.74M Sell
2,206,093
-228,596
-9% -$283K ﹤0.01% 2813
2025
Q1
$2.87M Sell
2,434,689
-80,135
-3% -$94.6K ﹤0.01% 2721
2024
Q4
$4.6M Buy
2,514,824
+157,145
+7% +$288K ﹤0.01% 2550
2024
Q3
$4.01M Sell
2,357,679
-146,597
-6% -$249K ﹤0.01% 2607
2024
Q2
$3.43M Sell
2,504,276
-38,621
-2% -$52.9K ﹤0.01% 2607
2024
Q1
$9.54M Sell
2,542,897
-154,796
-6% -$580K ﹤0.01% 2071
2023
Q4
$26.5M Sell
2,697,693
-121,072
-4% -$1.19M ﹤0.01% 1419
2023
Q3
$23.5M Buy
2,818,765
+3,004
+0.1% +$25.1K ﹤0.01% 1438
2023
Q2
$37.4M Buy
2,815,761
+276,619
+11% +$3.68M 0.01% 1162
2023
Q1
$29.4M Buy
2,539,142
+140,999
+6% +$1.63M 0.01% 1300
2022
Q4
$19.6M Sell
2,398,143
-15,933
-0.7% -$130K ﹤0.01% 1535
2022
Q3
$14M Buy
2,414,076
+294,991
+14% +$1.71M ﹤0.01% 1736
2022
Q2
$9.37M Buy
2,119,085
+139,317
+7% +$616K ﹤0.01% 2081
2022
Q1
$18M Sell
1,979,768
-4,190
-0.2% -$38.1K ﹤0.01% 1756
2021
Q4
$40.6M Sell
1,983,958
-318,587
-14% -$6.52M 0.01% 1264
2021
Q3
$58.8M Sell
2,302,545
-44,413
-2% -$1.13M 0.01% 960
2021
Q2
$82.1M Buy
2,346,958
+278,659
+13% +$9.74M 0.01% 778
2021
Q1
$68.9M Sell
2,068,299
-55,839
-3% -$1.86M 0.01% 879
2020
Q4
$55.1M Buy
2,124,138
+49,337
+2% +$1.28M 0.01% 997
2020
Q3
$20.5M Buy
2,074,801
+164,625
+9% +$1.62M ﹤0.01% 1608
2020
Q2
$6.59M Buy
1,910,176
+108,371
+6% +$374K ﹤0.01% 2354
2020
Q1
$5.51M Buy
1,801,805
+27,194
+2% +$83.2K ﹤0.01% 2245
2019
Q4
$9.12M Sell
1,774,611
-56,013
-3% -$288K ﹤0.01% 2234
2019
Q3
$9.45M Buy
1,830,624
+74,029
+4% +$382K ﹤0.01% 2184
2019
Q2
$10.6M Buy
1,756,595
+13,290
+0.8% +$80.4K ﹤0.01% 2116
2019
Q1
$12.6M Buy
1,743,305
+55,777
+3% +$403K ﹤0.01% 1999
2018
Q4
$12.5M Buy
1,687,528
+161,208
+11% +$1.19M ﹤0.01% 1922
2018
Q3
$8.26M Buy
1,526,320
+63,090
+4% +$341K ﹤0.01% 2372
2018
Q2
$5.2M Buy
1,463,230
+140,090
+11% +$497K ﹤0.01% 2664
2018
Q1
$2.71M Buy
1,323,140
+118,214
+10% +$242K ﹤0.01% 2952
2017
Q4
$3.18M Sell
1,204,926
-57,029
-5% -$151K ﹤0.01% 2870
2017
Q3
$6.63M Buy
1,261,955
+185,895
+17% +$976K ﹤0.01% 2453
2017
Q2
$3.83M Buy
1,076,060
+84,795
+9% +$302K ﹤0.01% 2780
2017
Q1
$5.13M Buy
991,265
+28,744
+3% +$149K ﹤0.01% 2542
2016
Q4
$3.66M Buy
962,521
+29,097
+3% +$111K ﹤0.01% 2755
2016
Q3
$8.36M Buy
933,424
+42,464
+5% +$380K ﹤0.01% 2194
2016
Q2
$6.27M Buy
890,960
+136,970
+18% +$964K ﹤0.01% 2317
2016
Q1
$6.41M Buy
753,990
+62,065
+9% +$528K ﹤0.01% 2262
2015
Q4
$9.09M Buy
691,925
+36,357
+6% +$477K ﹤0.01% 2082
2015
Q3
$2.4M Buy
655,568
+13,999
+2% +$51.2K ﹤0.01% 2933
2015
Q2
$3.7M Buy
641,569
+26,032
+4% +$150K ﹤0.01% 2709
2015
Q1
$3.59M Buy
615,537
+3,935
+0.6% +$23K ﹤0.01% 2719
2014
Q4
$4.8M Sell
611,602
-4,326
-0.7% -$33.9K ﹤0.01% 2532
2014
Q3
$3.02M Buy
615,928
+58,078
+10% +$285K ﹤0.01% 2833
2014
Q2
$3.45M Sell
557,850
-35,647
-6% -$220K ﹤0.01% 2770
2014
Q1
$3.18M Sell
593,497
-46,751
-7% -$250K ﹤0.01% 2853
2013
Q4
$3.35M Buy
640,248
+25,252
+4% +$132K ﹤0.01% 2834
2013
Q3
$3.4M Buy
614,996
+111,737
+22% +$617K ﹤0.01% 2758
2013
Q2
$1.27M Buy
+503,259
New +$1.27M ﹤0.01% 3201